-
FDA And Novartis Announce A Label Change For Iron Chelating Drug Exjade In Mid-February 2010
Includes A New "Black Box" Warning About Renal Impairment, Liver Failure, And Gastrointestinal Hemorrhage (Posted by Tom Lamb at DrugInjuryWatch.com) In mid-February 2010 the FDA and Novartis announced a change to the Prescribing Information…
-
Focus On Fosamax
________________________________________________________ Free Fosamax Case Evaluation The information you provide to us for this Free Case Evaluation will be treated as strictly confidential. You will get a reply from us no later than the next business…
-
Some Seroquel Documents From AstraZeneca Now Available At The Drug Industry Document Archive
These 241 "New" Documents Show How Drug Company Obscured Potential For Patient Weight Gain And Diabetes (Posted by Tom Lamb at DrugInjuryWatch.com) In mid-February 2010 Kim Klausner, the Industry Documents Digital Libraries Manager for…
-
Recent Report About Ortho Evra Safety Seems To Contradict Earlier Findings From Same Group
Third Boston Collaborative Drug Surveillance Program Study Analysis Concerning Ortho Evra And Blood Clot Side Effect Risk Causes Confusion (Posted by Tom Lamb at DrugInjuryWatch.com)Let us start with this relatively recent medical journal article, "Postmarketing study of…
-
YAZ, Yasmin, Ocella: 1,100 Lawsuits Filed As Of Mid-February 2010, According To Bayer
Company Annual Report 2009: "Bayer believes that it has meritorious defenses and intends to defend itself vigorously." (Posted by Tom Lamb at DrugInjuryWatch.com) The Bayer Annual Report for 2009, at page 243, provides some updated…
-
February 2010: Levaquin MDL Bellwether, Or Test, Cases Selected For First Trials
Six Plaintiffs Selected From Among The 300 Levaquin Lawsuits Filed To Date In Federal Court System (Posted by Tom Lamb at DrugInjuryWatch.com) At a February 12, 2010 Status Conference, U.S. District Judge John R.…